Advanced Science · 2022 · 52 citations · 29 references
MedicineCancer BiologyOncologyDrug DeliveryMolecular OncologyTumor MicroenvironmentCancer NanomedicineNanomedicineNanoparticle DesignNanotoxicologyPhotochemistryPhotodynamic TherapyCancer NanotherapyCancer Photodynamic TherapyEndosomal Escape DesignEntrapmentHypoxiaPhotodynamic Therapy NanomaterialsSinglet Oxygen GenerationTumor Microenvironment Hypoxia
Abstract Despite the clinical potential, photodynamic therapy (PDT) relying on singlet oxygen ( 1 O 2 ) generation is severely limited by tumor hypoxia and endosomal entrapment. Herein, a proton‐driven transformable 1 O 2 ‐nanotrap (ANBDP NPs) with endosomal escape capability is presented to improve hypoxic tumor PDT. In the acidic endosomal environment, the protonated 1 O 2 ‐nanotrap ruptures endosomal membranes via a “proton‐sponge” like effect and undergoes a drastic morphology‐and‐size change from nanocubes (≈94.1 nm in length) to nanospheres (≈12.3 nm in diameter). Simultaneously, anthracenyl boron dipyrromethene‐derived photosensitizer (ANBDP) in nanospheres transforms to its protonated form (ANBDPH) and switches off its charge‐transfer state to achieve amplified 1 O 2 photogeneration capability. Upon 730 nm photoirradiation, ANBDPH prominently produces 1 O 2 and traps generated‐ 1 O 2 in the anthracene group to form endoperoxide (ANOBDPH). Benefitting from the hypoxia‐tolerant 1 O 2 ‐release property of ANOBDPH in the dark, the 1 O 2 ‐nanotrap brings about sustained therapeutic effect without further continuous irradiation, thereby achieving remarkable antitumor performance.
29
Jonghoon Kim, Hye Rim Cho, Hyejin Jeon et al. · Journal of the American Chemical Society · 2017 · 708 citations
Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown
Anders Wittrup, Angela Ai, Xing Liu et al. · Nature Biotechnology · 2015 · 661 citations · Full text